Ibrance vs Revlimid
Different cancer types: Ibrance for breast cancer, Revlimid for multiple myeloma. Both are oral cancer therapies with patient assistance programs.
Side-by-Side Comparison
| Ibrance | Revlimid | |
|---|---|---|
| Generic Name | Palbociclib | Lenalidomide |
| Manufacturer | Pfizer | Bristol-Myers Squibb |
| FDA Uses | HR+/HER2- metastatic breast cancer | Multiple myeloma, Myelodysplastic syndromes, Mantle cell lymphoma |
| Dosing | 125mg daily for 21 days, 7 days off | 25mg daily for 21 days, 7 days off |
| Monthly Cost | $14,000 | $16,000 |
| With Insurance | $0–$2,000 | $0–$2,000 |
| Common Side Effects | Fatigue, Nausea, Hair thinning | Fatigue, Diarrhea |
Check what benefits you qualify for
Answer 9 questions. See every program you're eligible for. Free.
Frequently Asked Questions
Which is better, Ibrance or Revlimid?
Different cancer types: Ibrance for breast cancer, Revlimid for multiple myeloma. Both are oral cancer therapies with patient assistance programs. The best choice depends on your specific condition, insurance coverage, and how your body responds. Talk to your doctor about which is right for you.
Is Ibrance cheaper than Revlimid?
Ibrance costs $14,000/month while Revlimid costs $16,000/month without insurance. With insurance, copays may be similar depending on your plan's formulary.
Can I switch from Ibrance to Revlimid?
Switching between these medications should only be done under your doctor's supervision. They may need to adjust dosing and monitor for side effects during the transition.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.